ESTRO Brachytherapy for Prostate Cancer 2018

First page Table of contents Previous page 445 Next page Last page

IPSS Post Monotherapy

1mo

3mo 6mo 12mo 24mo

N

209 192 198 190 105

Median 9

7

6

6

6

Range 0-34 0-31

0-34 0-33 0-28

50

45

40

35

%

30

25

20

15

10

5

0

1mo

3mo

6mo

12mo

24mo

IPSS >10 (%)

IPSS >20 (%)

Made with FlippingBook - Online catalogs